Shimamura Lab

Registration is now open for the #GreatLakesChapter of @ASPET 2023 Annual Meeting at @UofIllinois Chicago on June 1st, 2023. The undergraduate, graduate student, and postdoctoral poster sessions are open to all topics in pharmacology. Register here: aspet.org/aspet/membersh…

Moscat @SBPdiscovery & colleagues discuss the dual roles of the atypical PKCs in cancer. cell.com/cancer-cell/fu…

Mayor Lori Lightfoot To Seek Total Ban On Flavored E-Cigarettes In Chicago cbsloc.al/2UY1NaZ#.XX_F7… Obviously, we agree. Well done @ChicagosMayor

Great job presenting our data at #WCLC2019 from our lab, Jeff! Got great feedback. @UICancerCenter

A new standard for EGFR-mutant NSCLC? nature.com/articles/s4157… #LCSM

In a analysis of pts from the FLAURA trial, osimertinib & the comparator treatment both provided longer PFS in plasma ctDNA EGFRm negative (23.5 and 15.0 months,) vs positive pats (15.2 and 9.7 months), potentially reflecting tumour burden: clincancerres.aacrjournals.org/content/early/… #LCSM #camoldx